Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22484434 | 0.92 | ABCC9 (0.30) | ABCC9 | |
| SCHEMBL26626365 | 0.87 | PDK2 (0.35) | PDK2 | |
| SCHEMBL23257676 | 0.86 | PDK2 (0.34) | PDK2 | |
| SCHEMBL21517523 | 0.85 | PDK2 (0.37) | PDK2 | |
| SCHEMBL21701657 | 0.85 | PDK2 (0.35) | PDK2 | |
| SCHEMBL22484830 | 0.84 | PGR (0.36) | PDK2 | |
| SCHEMBL15713669 | 0.84 | LPL (0.33) | — | |
| SCHEMBL30800709 | 0.84 | LPL (0.33) | — | |
| SCHEMBL21517353 | 0.84 | PDK2 (0.38) | PDK2ABCC9 | |
| SCHEMBL21343133 | 0.83 | OPRD1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737358-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-11737358-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20200303655-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-09-24 | — | — | US | disclosed |
| WO-2019182402-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2019-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737358-B2 | Compound and organic light emitting device comprising same | ARNT, CYP1A1, AHR | PDK2 3544/4885ABCC9 2094/4885 |
| US-20200303655-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | ARNT, CYP1A1, AHR | PDK2 3544/4885ABCC9 2094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.